精准医学的兴起:它能否在IBD中实现其承诺?
Stefan Schreiber1,2, Konrad Aden3,2, Florian Tran3,2
1Department Internal Medicine I, Kiel University, University Hospital Schleswig Holstein, Kiel, Germany s.schreiber@mucosa.de p.rosenstiel@mucosa.de.
Gut
|October 6, 2025
概括
针对炎症性肠病 (IBD) 的个性化治疗由于其复杂性而具有挑战性. 本综述提出了动态的,个性化的终点,将患者数据集成为主动IBD管理和改善结果.
科学领域:
- 胃肠病学 胃肠病学
- 精准医学是一门精准的医学.
- 分子生物学分子生物学
背景情况:
- 炎症性肠病 (IBD) 呈现出显著的临床和分子异质性,使个性化治疗复杂化.
- 目前IBD治疗反应的预测生物标志物缺乏,阻碍了量身定制的治疗策略.
研究的目的:
- 审查生物标志物引导精确治疗IBD的进展和局限性.
- 提出新的,个性化的终点来评估IBD的治疗结果.
主要方法:
- 文献综述评估了IBD当前的生物标志物引导精确疗法.
- 建议综合,纵向的终点结合患者报告的结果和分子分析.
- 类似于瘤学中最小残留疾病监测.
主要成果:
- 传统的二进制终点不足以捕捉IBD治疗反应的动态性质.
- 个性化,全面的疾病控制终点被提出为一个更全面的目标.
- 长期监测亚临床炎症和患者数据可以预测长期结果.
结论:
- 对治疗适应的动态,数据驱动的方法对于主动IBD管理至关重要.
- 整合纵向患者数据和分子分析可以指导早期治疗调整.
- 这种方法旨在将IBD管理从反应性转变为主动性,改善这种终身疾病的长期控制.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
490
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
490
Inflammatory Bowel Disease II: Crohn's Disease
952
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
952
Inflammatory Bowel Disease I: Ulcerative Colitis
894
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
894
Inflammatory Bowel Disease V: Surgical Management
450
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
450


